Chilton Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-120
Closed -$7.03K – 648
2024
Q1
$7.03K Hold
120
– – ﹤0.01% 496
2023
Q4
$6.48K Hold
120
– – ﹤0.01% 494
2023
Q3
$5.82K Hold
120
– – ﹤0.01% 453
2023
Q2
$6.78K Hold
120
– – ﹤0.01% 464
2023
Q1
$6.48K Buy
+120
New +$6.39K ﹤0.01% 482
2022
Q3
– Sell
-120
Closed -$6K – 400
2022
Q2
$6K Buy
+120
New +$6.54K ﹤0.01% 522
2022
Q1
– Sell
-120
Closed -$8K – 396
2021
Q4
$8K Buy
+120
New +$7.68K ﹤0.01% 523

Other funds holding IHI

Chilton Capital Management's IHI Position: Q2 2024 in Review

Chilton Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2024, closing a stake of 120 shares — an estimated $7.03K sold.

Chilton Capital Management first reported a position in IHI in Q4 2021 and held it in 7 quarters. The position peaked at $8K in Q4 2021. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2024.

  • Chilton Capital Management reported no remaining iShares US Medical Devices ETF position as of Q2 2024 after selling out during the quarter.
  • Chilton Capital Management sold 120 iShares US Medical Devices ETF shares in Q2 2024, an estimated $7.03K.
  • Chilton Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 7 quarters.
  • Chilton Capital Management's iShares US Medical Devices ETF position peaked at $8K in Q4 2021.
  • 546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2024.

Based on Chilton Capital Management's 13F filing for Q2 2024, filed 1 Aug 2024.